233 related articles for article (PubMed ID: 35633317)
21. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
23. A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.
Liu R; Feng Y; Deng Y; Zou Z; Ye J; Cai Z; Zhu X; Liang Y; Lu J; Zhang H; Luo Y; Han Z; Zhuo Y; Xie Q; Hon CT; Liang Y; Wu CL; Zhong W
J Exp Clin Cancer Res; 2021 Jun; 40(1):188. PubMed ID: 34098990
[TBL] [Abstract][Full Text] [Related]
24. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
25. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2.
Cheng L; Cao H; Xu J; Xu M; He W; Zhang W; Dong L; Chen D
J Bioenerg Biomembr; 2021 Aug; 53(4):415-428. PubMed ID: 34036483
[TBL] [Abstract][Full Text] [Related]
26. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
27. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
28. ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
Tanaka K; Kandori S; Sakka S; Nitta S; Tanuma K; Shiga M; Nagumo Y; Negoro H; Kojima T; Mathis BJ; Shimazui T; Watanabe M; Sato TA; Miyamoto T; Matsuzaka T; Shimano H; Nishiyama H
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34841437
[TBL] [Abstract][Full Text] [Related]
29. N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.
Miao D; Wang Q; Shi J; Lv Q; Tan D; Zhao C; Xiong Z; Zhang X
Cancer Commun (Lond); 2023 Apr; 43(4):480-502. PubMed ID: 36860124
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy.
Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y
J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060
[TBL] [Abstract][Full Text] [Related]
31. Lipid in Renal Carcinoma: Queen Bee to Target?
Tan SK; Welford SM
Trends Cancer; 2020 Jun; 6(6):448-450. PubMed ID: 32459999
[TBL] [Abstract][Full Text] [Related]
32. HIF2α-induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma.
Quan Y; Dai J; Zhou S; Zhao L; Jin L; Long Y; Liu S; Hu Y; Liu Y; Zhao J; Ding Z
FEBS Open Bio; 2023 Apr; 13(4):638-654. PubMed ID: 36728187
[TBL] [Abstract][Full Text] [Related]
33. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
[TBL] [Abstract][Full Text] [Related]
34. Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.
Yang H; Zhao H; Ren Z; Yi X; Zhang Q; Yang Z; Kuang Y; Zhu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):220-231. PubMed ID: 35130611
[TBL] [Abstract][Full Text] [Related]
35. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
38. Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.
Lou W; Gao K; Xu C; Li Q
IUBMB Life; 2021 Nov; 73(11):1334-1347. PubMed ID: 34415102
[TBL] [Abstract][Full Text] [Related]
39. SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling.
Yang H; Zhang X; Liu F; Fan J; Wang B; Dong C
Biochem Biophys Res Commun; 2018 Jan; 495(1):1383-1388. PubMed ID: 29183723
[TBL] [Abstract][Full Text] [Related]
40. Identification of candidate biomarker
Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]